This year, intellectual property (IP) law and policy directly addressed the realities of generative artificial intelligence (AI). With a new director at the helm, the U.S. Patent and Trademark Office (USPTO) issued new...more
1/23/2026
/ Artificial Intelligence ,
Copyright ,
Innovation ,
Intellectual Property Protection ,
Inventions ,
Machine Learning ,
New Guidance ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Regulatory Oversight ,
Software Patents ,
Trademarks ,
USPTO
FDA recently issued two draft guidance documents discussing: (1) the use of artificial intelligence (AI) to produce information to support a regulatory decision about a drug or biological product’s safety, effectiveness, or...more
1/15/2025
/ Artificial Intelligence ,
Biologics ,
Data Management ,
Draft Guidance ,
Filing Requirements ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Machine Learning ,
Medical Devices ,
Pharmaceutical Industry ,
Popular ,
Public Comment ,
Regulatory Requirements ,
Risk Management